Managing the oral side‐effects of medications used to treat multiple sclerosis
- 31 May 2017
- journal article
- Published by Wiley in Australian Dental Journal
- Vol. 62 (3), 331-336
- https://doi.org/10.1111/adj.12510
Abstract
Many medications used to manage multiple sclerosis (MS) affect oral health. This review aimed to identify the oral side-effects of the current drugs recommended in Australia to treat MS and make dental practitioners aware of the range of symptoms. The Australian Therapeutic Guidelines and the Australian Medicines Handbook were searched for medications used to treat MS. For each medication, the generic name, class, route of administration, dosage and drug company reported side-effects were extracted from the online Monthly Index of Medical Specialties (MIMs) database. Meyler's Side-effect of Drugs Encyclopaedia was used to identify any additional oral adverse reactions to medications used to treat MS. Fourteen drugs were identified for the treatment of MS progression and 13 drugs for the treatment of MS symptoms. For these medications, 18 oral side-effects were documented: xerostomia was the most common, followed by dysgeusia, dysphagia, mouth ulceration and sinusitis. Anticholinergic drugs caused xerostomia while immunosuppressants resulted in more infection-related side-effects. Dental practitioners should be aware of the range of symptoms likely to be reported by this population. Clinicians are encouraged to continue providing dental care for their patients who develop MS and refer complex cases to specialists.Keywords
This publication has 30 references indexed in Scilit:
- Oral health status of a population with multiple sclerosisMedicina Oral Patología Oral y Cirugia Bucal, 2012
- Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimusJournal of Clinical Periodontology, 2010
- Multiple sclerosis: Geoepidemiology, genetics and the environmentAutoimmunity Reviews, 2010
- Communicating the diagnosis of multiple sclerosis - a qualitative studyMultiple Sclerosis Journal, 2007
- Prevalence, Severity, and Risk Variables Associated With Gingival Overgrowth in Renal Transplant Subjects Treated Under Tacrolimus or Cyclosporin RegimensThe Journal of Periodontology, 2006
- Atypical Odontalgia: A Review of the LiteratureHeadache: The Journal of Head and Face Pain, 2003
- Multiple SclerosisAnnual Review of Medicine, 2002
- Management of Multiple SclerosisThe New England Journal of Medicine, 1997
- A preliminary study into the dental health status of multiple sclerosis patientsSpecial Care in Dentistry, 1993
- Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infectionsActa Odontologica Scandinavica, 1990